Back

Achievement of ESC/EAS lipid treatment goals with evolocumab in patients with type 2 diabetes: analyses of the BANTING and BERSON trials

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention ePosters Lipids ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Alberto Juan Lorenzatti

DAMIC Medical Institute, Cordoba (Argentina)

217 More presentations in this session

Presentation thumbnail
The association between napping and the risk of cardiovascular disease and all-cause mortality: a systematic review and dose-response meta-analysis
Doctor Z. Pan (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Prediction of 10-year and lifetime risk of cancer in individual patients with established cardiovascular disease, results from UCC-SMART and CANTOS
Miss C. van 't Klooster (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Geographical profiles of cardiovascular risk and the risk factors in China: data from a nationwide population-based screening project
Assistant Professor C. Wu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Associations between life-course frailty and later-life heart size and function in the 1946 NSHD British birth cohort-an epidemiological study
Mr C. Topriceanu (London, GB)
Abstract Slides
Presentation thumbnail
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
Doctor P. Welsh (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Risk Factors and Prevention ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
LDL-C goal achievement and lipid-lowering therapy in patients by atherosclerotic cardiovascular disease subtype: the SANTORINI study
27 August 2022
thumbnail
Congress Presentation
Specificities of dyslipidemia management in diabetic patients.
28 August 2022
thumbnail
Congress Presentation
Does Evolocumab use in Europe match 2019 ESC/EAS lipid guidelines? Results from the HEYMANS study
30 August 2020
thumbnail
Congress Presentation
Association of body mass index with non-achievement of target low-density lipoprotein level in older patients at very high cardiovascular risk: a multicentre study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources